Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-740-9 | CAS number: 162492-07-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From January 17, 2017 to March 05, 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Justification for study design:
- The dose levels were selected based on available acute oral toxicity data (LD50 > 2000 mg/kg bw in rats and based on the results of the Dose Range Finding (DRF) study. The aim was to induce toxic effects but ideally no death or suffering at the highest dose and a NOAEL at the lowest dose level. During the Dose Range Finding study, no treatment related adverse effects were seen at dose levels of 100, 300 or 1000 mg/kg bw/day.
- Specific details on test material used for the study:
- CAS No.: 162492-07-1; EC No.: 500-740-9; Batch No.: 1591ZG-101; Purity: ca. 100 %; Appearance: white fine powder
- Species:
- rat
- Strain:
- Wistar
- Details on species / strain selection:
- The rat is regarded as a suitable species for toxicology and reproduction toxicology studies. Wistar rat was selected due to experience with this strain of rat in toxicity and reproduction toxicity studies and known fertility. Crl:WI rats were used for dose range finding study.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Species and strain: Crl:WI Wistar rats
Source: Charles River Laboratories, Research Models and Services, Germany, from SPF colony
Hygienic conditions: standard laboratory conditions
Number of animals: 48 male, 48 female rats, 12 animals/sex/group, 4 groups
Age of animals: young adult rats, approximately 10 weeks old at start and 12 weeks old at mating
Body weight range: males: 408-443 g, females: 240-267 g; did not exceed ±20 % of the mean weight for each sex at onset of treatment
Acclimation period: 5 days
Husbandry
Animal health: only healthy animals were used for the test, as certified by the clinical veterinarian. Females were nulliparous and non-pregnant.
Cage type: type II polycarbonate
Bedding: LIGNOCEL ¾ S certified wooden chips produced by J. Rettenmaier & Söhne GmbH+Co.KG, Germany
Nesting: Arbocel nest building material produced by J. Rettenmaier & Söhne GmbH+Co.KG, Germany
Light: 12 hours daily
Temperature: 19.0 – 24.8 °C
Relative humidity: 24 – 69 %
Ventilation: 15-20 air exchanges/hour
Housing/Enrichment: rodents were group-housed, up to 4 animals of the same sex and dose group/cage with the exception of the mating and gestation/delivery period when they were paired or individually housed, respectively
Food and water supply
Animals received ssniff SM R/M "Autoclavable complete diet for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, Germany, ad libitum, and tap water from the municipal supply from a 500 mL bottle, ad libitum. The food is considered not to contain any contaminants that could reasonably be expected to affect the purpose or integrity of the study.
Animal identification
Each parental/adult animal (P Generation) was identified by a unique number within the study, written with indelible ink on the tail. - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- The test substance was formulated in the vehicle with a pestle and mortal or with a “Ultra Turrax T-25” mixer. Formulations were prepared daily. The dosing solutions were administered to the test substance or vehicle-treated (control) animals daily on a 7 days/week basis, by oral gavage using a tipped gavage needle attached to a syringe. A constant volume of 5 mL/kg bw were administered to all animals. The actual volume to be administered were calculated and adjusted based on each animal’s most recent body weight.
- Details on mating procedure:
- Mating began after the animals had attained full sexual maturity, 2 weeks after the initiation of treatment, with one female and one male from the same dose group (1:1 mating) in a single cage. Females remained with the same male until copulation occurred, for up to 5 days. A vaginal smear was prepared daily during the mating period and stained with 1 % aqueous methylene blue solution. The smears were examined with a light microscope. The presence of a vaginal plug or sperm in the vaginal smear was considered as evidence of copulation (Day 0 of pregnancy as defined by the relevant guidelines). Sperm positive females were housed individually.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analysis of test substance formulations for concentration and homogeneity was performed using a validated LC-MS Method. Top, middle and bottom duplicate samples were taken and analysed from test substance formulations on 3 occasions. One set was collected for analysis and one set as a back-up, if required for any confirmatory analyses. Similarly, one sample was taken on each occasion in duplicate from the middle of the vehicle control solution (Group 1) to confirm the absence of test substance.
- Duration of treatment / exposure:
- Dosing of both sexes began after 5 days acclimatisation and 2 weeks before mating, during the mating, and were continued up to and including the day before the necropsy.
Males were dosed for 28 days (14 days pre-mating and 14 days mating/post-mating) and then euthanized and subjected to necropsy examination.
Females were dosed for 14 days pre-mating, during the mating period, through gestation and until the day before the necropsy (4-day post-partum dosing). The day of birth (when parturition was complete) was defined as Day 0 post-partum (PPD 0). - Frequency of treatment:
- daily
- Details on study schedule:
- Dosing scheme, Male animals:
Acclimatisation: 5 days
Pre-mating period: 14 days
Mating/Post-mating period: at least 14 days (Last week of treatment: FOB, Day 24, 5 animals/group, Prior to/at necropsy examinations
Dosing scheme, Female animals:
Acclimatisation period: 5 days
Pre-mating period: 14 days
Mating: up to 5 days
Gestation: 22-24 days
Delivery
Lactation period: at least 4 days, FOB: (PND 4, 5 animals/group); Pups necropsy, (PND 4)
PND 5: Prior to/at necropsy examinations
All F1 offspring were terminated on Day 4 post-partum. In order to allow for overnight fasting of dams prior to urine collection on PPD 5, the offspring were euthanized on PPD/PND 4 and the dams on PPD/PND 5. - Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 100 mg/kg bw/day
- Dose / conc.:
- 300 mg/kg bw/day
- Dose / conc.:
- 1 000 mg/kg bw/day
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Observation of the delivery process, offspring and nursing instinct:
Females were allowed to litter and rear their offspring. The delivery process was observed as carefully as possible. Any evidence of abnormal deliveries was recorded. The duration of gestation was recorded and was calculated from Day 0 of pregnancy until the completion of parturition.
Dams were observed for signs of nest building with the bedding material and for covering their new-borns. Evidence of suckling was observed by the presence of milk in the pups' stomach. All observations were recorded.
Each litter was examined as soon as possible after delivery to establish the number and sex of pups, stillbirths, live births, runts (pups that are apparently smaller than normal pups) and to detect the presence of gross abnormalities. Observations were reported individually for each adult animal. In addition to the observations on parent animals, any abnormal behaviour of the offspring was recorded.
Live pups were counted, sexed, weighed individually within 24 hours of parturition (PND 0 or 1) and on PND 4, with accuracy of 0.01 g. All litters were checked and recorded daily for the number of viable and dead pups. The pups found dead and intact (not cannibalized) were subjected to necropsy with macroscopic examination and the cause of death was identified if possible. All observed abnormalities were recorded. All pups were culled on PND 4. - Parental animals: Observations and examinations:
- The reproductive performance, pregnancy, parturition and post-partum/lactation period were monitored in the adult animals
- Sperm parameters (parental animals):
- Special attention was paid to the evaluation of the stages of spermatogenesis in the male gonads and histopathology of interstitial testicular cell structure. Detailed histological examination of the ovaries covered the follicular, luteal, and interstitial compartments of the ovary, as well as the epithelial capsule and ovarian stroma.
- Litter observations:
- The viability, clinical signs and development were evaluated in their F1 offspring until post-natal Day (PND) 4.
- Postmortem examinations (parental animals):
- Organ weight measurements:
At the time of termination, body weight and the weight of the following organs from all adult animals were determined:
- With a precision of 0.001 g: adrenals, ovaries, thyroids with parathyroids
Testes and epididymides were weighed individually.
For the adult animals, a detailed histological examination was performed as follows:
- on the selected list of retained organs in the Control and High dose groups (selected 5 animals/sex/group),
- all macroscopic findings (abnormalities), except of minor order from all animals,
- retained reproductive organs (testes, epididymides, prostate gland, seminal vesicles with coagulation gland for males and uterus, cervix, ovary, oviduct and vagina for females) of all animals of the Control and High dose groups and additionally of the one male that failed to sire and the one female that failed to deliver healthy pups. - Postmortem examinations (offspring):
- Macroscopic Findings
On PND 0, there were 3 Low Dose and 9 Mid Dose pups found dead that remained intact (not cannibalized or autolysed). Those were subjected to necropsy with macroscopic examination. No test substance-related macroscopic findings were seen. No other pups that died during the lactation period could be examined for test substance-related macroscopic findings.
Organ weights
Compared to the control, there were no statistically significant differences in mean values recorded in any of the dose groups. - Statistics:
- Data was recorded on the appropriate forms from the relevant SOPs of the labolatory and then tabulated using the Microsoft Office Word and/or Excel, or using the software PROVANTIS v.9, as appropriate. Numerical data obtained during the conduct of the study was subjected as appropriate to calculation of group means
and standard deviations. - Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- No test substance related clinical signs were observed during the study. One female animal in the Low dose group had piloerection on Day 41. Based on the very low incidence and lack of dose response, this observation was considered to be incidental.
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Significantly higher sodium (p<0.01), chloride (p<0.01), total protein (p<0.05) and bile acid (p<0.05) concentrations were recorded for High dose (1000 mg/kg bw/day) males. No such things were seen in females. These findings are within the historical control range. Due to the incidental appearances and the lack of any supporting evidence of any changes in these animals (histopathology, urinalysis, etc.) and as the recorded values are within the historical control range, these differences were considered to not reflect any adverse effects of the test substance.
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Other effects:
- not specified
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No substance-related effects observed at any dose
- Key result
- Critical effects observed:
- no
- Clinical signs:
- effects observed, non-treatment-related
- Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- mortality observed, non-treatment-related
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- effects observed, non-treatment-related
- Histopathological findings:
- effects observed, non-treatment-related
- Other effects:
- not specified
- Behaviour (functional findings):
- not examined
- Developmental immunotoxicity:
- not examined
- Key result
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No substance-related effects observed at any dose
- Key result
- Critical effects observed:
- no
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- Under the study conditions, the NOAEL was considered to be 1000 mg/kg bw/day for the female and male parental/adult generation, and also for the F1/pups generation.
- Executive summary:
A study was conducted to determine the reproductive/developmental toxicity of the test substance when administered to Crl:WI Wistar rats according to OECD Guideline 422, in compliance with GLP. The screening test intended to provide initial information on possible effects on male and female reproductive performance such as gonadal function, mating behaviour, conception, pregnancy, parturition and development of the F1 offspring from conception to post-partum Day (PPD) 4. The details on systemic effects are summarised in section ‘Repeated dose toxicity: oral’. Male and female Wistar rats were treated for 2 weeks pre-mating and then during the mating/post-mating periods. This corresponded to 28 d in total for males. Females were treated throughout gestation and up to and including post-partum/lactation Day (PPD) 4. The test substance, formulated in corn oil, was administered by oral gavage to test animals. One control group and three treated groups were tested (100, 300 and 1000 mg/kg bw), each consisting of 12 males and 12 females. The reproductive performance, pregnancy, parturition and post-partum/lactation period were monitored in the adult animals, and viability, clinical signs and development were evaluated in their F1 offspring until post-natal Day (PND) 4. No test substance related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD 5. There were no adverse effects on the F1 offspring viability, clinical signs, development or at observations following euthanasia. Under the study conditions, the NOAEL was considered to be 1000 mg/kg bw/day for the female and male parental/adult generation, and also for the F1/pups generation (Weisz, 2017).
Reference
All the dose formulations were homogenous. The measured concentrations of the test substance evaluated for each test substance-dose group varied between 91 % and 105 % of the nominal contents. No test substance was detected in the control samples. These results were within the acceptable ranges (85% - 115%) and were considered suitable for the study purposes.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Toxicity to reproduction
A study was conducted to determine the reproductive/developmental toxicity of the test substance when administered to Crl:WI Wistar rats according to OECD Guideline 422, in compliance with GLP. The screening test intended to provide initial information on possible effects on male and female reproductive performance such as gonadal function, mating behaviour, conception, pregnancy, parturition and development of the F1 offspring from conception to post-partum Day (PPD) 4. The details on systemic effects are summarised in section ‘Repeated dose toxicity: oral’. Male and female Wistar rats were treated for 2 weeks pre-mating and then during the mating/post-mating periods. This corresponded to 28 d in total for males. Females were treated throughout gestation and up to and including post-partum/lactation Day (PPD) 4. The test substance, formulated in corn oil, was administered by oral gavage to test animals. One control group and three treated groups were tested (100, 300 and 1000 mg/kg bw), each consisting of 12 males and 12 females. The reproductive performance, pregnancy, parturition and post-partum/lactation period were monitored in the adult animals, and viability, clinical signs and development were evaluated in their F1 offspring until post-natal Day (PND) 4. No test substance related changes were noted in the reproductive parameters during mating and gestation, delivery and post-partum/lactation period until PPD 5. There were no adverse effects on the F1 offspring viability, clinical signs, development or at observations following euthanasia. Under the study conditions, the NOAEL was considered to be 1000 mg/kg bw/day for the female and male parental/adult generation, and also for the F1/pups generation (Weisz, 2017).
Effects on developmental toxicity
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results of a combined 28 d oral toxicity study with a reproduction/developmental toxicity screening, the test substance does not need to be classified for reproductive toxicity according to CLP (EC 1272/2008) criteria.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.